|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ziegler RG, Anderson WF and Gail MH:
Increasing breast cancer incidence in China: The numbers add up. J
Natl Cancer Inst. 100:1339–1341. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu
L and He J: Report of incidence and mortality in China cancer
registries, 2009. Chin J Cancer Res. 25:10–21. 2013.PubMed/NCBI
|
|
5
|
No authors listed, . Adjuvant therapy for
breast cancer. NIH Consens Statement. 17:1–35. 2000.
|
|
6
|
No authors listed, . NIH consensus
conference. Treatment of early-stage breast cancer. JAMA.
265:391–395. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bonadonna G and Valagussa P: Dose-response
effect of adjuvant chemotherapy in breast cancer. N Engl J Med.
304:10–15. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Muss HB, Berry DA, Cirrincione CT,
Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG,
Cohen HJ, Becker HP, et al: CALGB Investigators: Adjuvant
chemotherapy in older women with early-stage breast cancer. N Engl
J Med. 360:2055–2065. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Doll R: Strategy for detection of cancer
hazards to man. Nature. 265:589–596. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vanhuyse M, Fournier C and Bonneterre J:
Chemotherapy-induced amenorrhea: influence on disease-free survival
and overall survival in receptor-positive premenopausal early
breast cancer patients. Ann Oncol. 16:1283–1288. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
BenAharon I, Meizner I, Granot T, Uri S,
Hasky N, Rizel S, Yerushalmi R, Sulkes A and Stemmer SM:
Chemotherapy-induced ovarian failure as a prototype for acute
vascular toxicity. Oncologist. 17:1386–1393. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Reinisch M, von Minckwitz G, Harbeck N,
Janni W, Kümmel S, Kaufmann M, Elling D, Nekljudova V and Loibl S:
Side effects of standard adjuvant and neoadjuvant chemotherapy
regimens according to age groups in primary breast cancer. Breast
Care (Basel). 8:60–66. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rosendahl M, Ahlgren J, Andersen J, Bergh
J, Blomquist C, Lidbrink E, Lindman H, Mouridsen H, Bjerre K and
Andersson M: The risk of amenorrhoea after adjuvant chemotherapy
for early stage breast cancer is related to inter-individual
variations in chemotherapy-induced leukocyte nadir in young
patients: Data from the randomised SBG 2000-1 study. Eur J Cancer.
45:3198–3204. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jingang A: Which future for doctors in
China? Lancet. 382:936–937. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Goss PE, StrasserWeippl K, LeeBychkovsky
BL, et al: Challenges to effective cancer control in China, India,
and Russia. Lancet Oncol. 15:489–538. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lipscomb J, Gillespie TW, Goodman M,
Richardson LC, Pollack LA, Ryerson AB and Ward KC: Black-white
differences in receipt and completion of adjuvant chemotherapy
among breast cancer patients in a rural region of the US. Breast
Cancer Res Treat. 133:285–296. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hershman DL, Unger JM, Barlow WE, Hutchins
LF, Martino S, Osborne CK, Livingston RB and Albain KS: Treatment
quality and outcomes of African American versus white breast cancer
patients: Retrospective analysis of Southwest Oncology studies
S8814/S8897. J Clin Oncol. 27:2157–2162. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
National Comprehensive Cancer Network
(NCCN), . NCCN Clinical Practice Guidelines in Oncology. Breast
Cancer; Fort Washington, PA: pp. 66–69. 2012
|
|
19
|
Kilickap S and Arslan C: Adjuvant
chemotherapy and prognosis in patients with breast cancer. Ann
Oncolo. 20:192–193; author reply 193–194. 2009. View Article : Google Scholar
|
|
20
|
Fisher ER, Redmond C and Fisher B:
Pathologic findings from the National Surgical Adjuvant Breast
Project. VIII. Relationship of chemotherapeutic responsiveness to
tumor differentiation. Cancer. 51:181–191. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fisher B and Redmond C: Systemic therapy
in node-negative patients: updated findings from NSABP clinical
trials. National Surgical Adjuvant Breast and Bowel Project. J Ntl
Cancer Inst Monogr. 105–116. 1992.
|
|
22
|
Goldhirsch A, Glick JH, Gelber RD, Coates
AS and Senn HJ: Meeting highlights: International Consensus Panel
on the Treatment of Primary Breast Cancer. Seventh International
Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin
Oncol. 19:3817–3827. 2001.PubMed/NCBI
|
|
23
|
Rao RD and Cobleigh MA: Adjuvant endocrine
therapy for breast cancer. Oncology (Williston Park). 26:541–547,
550, 552 passim. 2012.PubMed/NCBI
|
|
24
|
Richardson LC, Tian L, Voti L, Hartzema
AG, Reis I, Fleming LE and Mackinnon J: The roles of teaching
hospitals, insurance status, and race/ethnicity in receipt of
adjuvant therapy for regional-stage breast cancer in Florida. Am J
Public Health. 96:160–166. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Silliman RA, Guadagnoli E, Weitberg AB and
Mor V: Age as a predictor of diagnostic and initial treatment
intensity in newly diagnosed breast cancer patients. J Gerontol.
44:M46–M50. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Du XL, Key CR, Osborne C, Mahnken JD and
Goodwin JS: Discrepancy between consensus recommendations and
actual community use of adjuvant chemotherapy in women with breast
cancer. Ann Intern Med. 138:90–97. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bickell NA, Aufses AH Jr and Chassin MR:
The quality of early-stage breast cancer care. Ann Surg.
232:220–224. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bradley CJ, Given CW and Roberts C: Race,
socioeconomic status, and breast cancer treatment and survival. J
Natl Cancer Inst. 94:490–496. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Y, Gao H, Bu Y, Fan X and Jia J:
Factors associated with receipt of adjuvant chemotherapy among
married women with breast cancer. World J Surg Oncol. 11:2862013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang Y, Bu Y and Gao H: Rural-urban
disparities of breast cancer patients in China. Med Oncol.
30:3872013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Giordano SH, Duan Z, Kuo YF, Hortobagyi GN
and Goodwin JS: Use and outcomes of adjuvant chemotherapy in older
women with breast cancer. J Clin Oncol. 24:2750–2756. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Buist DS, Chubak J, Prout M, Yood MU,
Bosco JL, Thwin SS, Gold HT, Owusu C, Field TS, Quinn VP, et al:
Referral, receipt, and completion of chemotherapy in patients with
early-stage breast cancer older than 65 years and at high risk of
breast cancer recurrence. J Clin Oncol. 27:4508–4514. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bouchardy C, Rapiti E, Fioretta G, Laissue
P, NeyroudCaspar I, Schäfer P, Kurtz J, Sappino AP and Vlastos G:
Undertreatment strongly decreases prognosis of breast cancer in
elderly women. J Clin Oncol. 21:3580–3587. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Du X and Goodwin JS: Patterns of use of
chemotherapy for breast cancer in older women: Findings from
Medicare claims data. J Clin Oncol. 19:1455–1461. 2001.PubMed/NCBI
|
|
35
|
Mandelblatt JS, Sheppard VB, Hurria A,
Kimmick G, Isaacs C, Taylor KL, Kornblith AB, Noone AM, Luta G,
Tallarico M, et al: Cancer Leukemia Group B: Breast cancer adjuvant
chemotherapy decisions in older women: The role of patient
preference and interactions with physicians. J Clin Oncol.
28:3146–3153. 2010. View Article : Google Scholar : PubMed/NCBI
|
